Calculators हिहिन्दी
Advanced Obstetrics guide

Twin and Multiple Pregnancy

Why chorionicity matters, how surveillance differs and how preterm-birth risk is reduced.

Twin and triplet pregnancy needs additional surveillance because risks depend not only on the number of babies but on whether they share a placenta or amniotic sac. Determining chorionicity early is one of the most important first steps.

A first-trimester scan should establish gestation, chorionicity and amnionicity whenever possible.
Babies sharing a placenta need more frequent ultrasound because of twin-to-twin transfusion and related complications.
Preterm birth is common, so cervical-length assessment, symptom awareness and neonatal planning are important.
Original educational diagram for Twin and Multiple Pregnancy
Original SVG created in this project for this topic. Simplified for patient education; not a diagnostic image and not to scale.
Evidence check • 21 July 2026

NICE NG137 updated in April 2024

The 2024 update added a single cervical-length scan and vaginal progesterone for a short cervix in twin or triplet pregnancy.

  • Offer a cervical-length scan between 16 and 20 weeks in twin or triplet pregnancy.
  • If cervical length is 25 mm or less, NICE recommends vaginal progesterone 200 mg nightly until 34 weeks or birth if earlier; this must be prescribed and monitored locally.
  • Routine bed rest, cervical cerclage, pessary, oral tocolytics and intramuscular progesterone are not recommended solely to prevent preterm birth in multiple pregnancy.
  • Planned birth timing depends on chorionicity and complications; uncomplicated dichorionic twins are generally planned later than monochorionic twins.

Chorionicity and amnionicity

Dichorionic twins have separate placentas; monochorionic twins share one. Diamniotic twins have separate sacs; monoamniotic twins share a sac. These distinctions affect surveillance and birth planning more than whether the twins are identical.

The lambda and T signs on first-trimester ultrasound help determine placental sharing. When uncertain, the pregnancy is managed cautiously.

Maternal and fetal risks

Maternal risks include anaemia, hyperemesis, hypertension, gestational diabetes, thrombosis and postpartum haemorrhage. Fetal risks include preterm birth, growth discordance and complications unique to a shared placenta.

Monochorionic twins are monitored for twin-to-twin transfusion syndrome, selective growth restriction and twin anaemia–polycythaemia sequence.

Scan schedule and growth

The scan frequency is based on chorionicity. Growth is assessed for each baby and the percentage weight discordance is calculated. Significant discordance or abnormal Doppler findings prompt specialist review.

One fetal demise, major anomaly or severe growth difference requires fetal-medicine counselling because risks and options depend strongly on placental sharing.

Birth planning

Timing and mode of birth depend on chorionicity, presentation of the first baby, gestation, growth and complications. Vaginal birth can be appropriate for selected twin pregnancies when the first baby is head-down and an experienced team is available.

Neonatal care, analgesia, continuous monitoring and management of the third stage are planned in advance because preterm birth and postpartum haemorrhage are more common.

Deeper clinical context

Placental sharing changes the plan

DCDA

Two placentas and two sacs; lower shared-placenta risk but still needs twin-specific growth surveillance.

MCDA

One placenta and two sacs; requires frequent monitoring for transfusion and growth complications.

MCMA

One placenta and one sac; rare and highest risk, requiring specialist fetal-medicine care.

When to seek urgent careSeek urgent maternity care for reduced movement of either baby, fluid leakage, bleeding, regular contractions, severe headache, visual symptoms, sudden swelling or severe abdominal pain.
Medical note: This page is general education, not a diagnosis or personal treatment plan. Recommendations and medicine protocols vary with gestation, clinical findings and local services. Dr. Akrati Jain should clinically approve the page before publication.